(19)

(11)

EP 4 562 594 A1

(12)

(43) Date of publication: 04.06.2025 Bulletin 2025/23 (21) Application number: 23757770.5 (22) Date of filing: 28.07.2023

(51) International Patent Classification (IPC):  G06T 7/00(2017.01) (52) Cooperative Patent Classification (CPC): G06T 7/0012; G06T 2207/10056; G06T 2207/20084; G06T 2207/20081; G06T 2207/30088; G06T 2207/30024 (86) International application number: PCT/US2023/029002 (87) International publication number: WO 2024/026104 (01.02.2024 Gazette 2024/05)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: KH MA MD TN (30) Priority: 28.07.2022 US 202263369739 P (71) Applicant: Teva Branded Pharmaceutical Products R&D, Inc. West Chester, PA 19380 (US)	(72) Inventor: MASCARENHAS, Felipe Mello Chester, PA 19380 (US) (74) Representative: D Young & Co LLP  3 Noble Street London EC2V 7BQ London EC2V 7BQ (GB)